Subcutaneous granulomatous lesions related to ritonavir therapy in a HIV infected patient.
We report a case of subcutaneous granulomatous lesions developed in a HIV seropositive man, related to ritonavir therapy. The importance of close monitoring and investigations of patients developing unusual side effects during highly active antiretroviral therapy (HAART) is demonstrated.
Kawsar
M
M
Ambrose King Centre, Department of GU Medicine, The Royal London Hospital, Whitechapel, London, UK. ambrose.king@dial.pipex.com
El-Gadi
S
S
D006099:Granuloma / Q000139:chemically induced*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019438:Ritonavir / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced*
D017320:HIV Protease Inhibitors; D019438:Ritonavir